Review



primary human umbilical artery smcs (huasmcs)  (Lonza)


Bioz Verified Symbol Lonza is a verified supplier
Bioz Manufacturer Symbol Lonza manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Lonza primary human umbilical artery smcs (huasmcs)
    Primary Human Umbilical Artery Smcs (Huasmcs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs/pm26987444-27-0-7?v=Lonza
    Average 90 stars, based on 1 article reviews
    primary human umbilical artery smcs (huasmcs) - by Bioz Stars, 2026-07
    90/100 stars

    Images



    Similar Products

    human umbilical artery smcs huasmcs  (Procell Inc)
    86
    Procell Inc human umbilical artery smcs huasmcs
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs Huasmcs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs/pmc12433515-134-5-15?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    human umbilical artery smcs huasmcs - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    human umbilical artery smooth muscle cells smcs  (PromoCell)
    94
    PromoCell human umbilical artery smooth muscle cells smcs
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smooth Muscle Cells Smcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs/pm40778606-504-132-141?v=PromoCell
    Average 94 stars, based on 1 article reviews
    human umbilical artery smooth muscle cells smcs - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    primary human umbilical artery smcs (huasmcs)  (Lonza)
    90
    Lonza primary human umbilical artery smcs (huasmcs)
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Primary Human Umbilical Artery Smcs (Huasmcs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs/pm26987444-27-0-7?v=Lonza
    Average 90 stars, based on 1 article reviews
    primary human umbilical artery smcs (huasmcs) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs (huasmcs)  (ScienCell)
    90
    ScienCell human umbilical artery smcs (huasmcs)
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs (Huasmcs), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs/pm27959397-30-0-8?v=ScienCell
    Average 90 stars, based on 1 article reviews
    human umbilical artery smcs (huasmcs) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs (huasmcs) (clonetics, lonza, cat. no. cc-2579)  (Lonza)
    90
    Lonza human umbilical artery smcs (huasmcs) (clonetics, lonza, cat. no. cc-2579)
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs (Huasmcs) (Clonetics, Lonza, Cat. No. Cc 2579), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs/pmc04059065-64-28-34?v=Lonza
    Average 90 stars, based on 1 article reviews
    human umbilical artery smcs (huasmcs) (clonetics, lonza, cat. no. cc-2579) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs (huasmcs)  (Lonza)
    90
    Lonza human umbilical artery smcs (huasmcs)
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs (Huasmcs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs/pmc04059065-169-27-33?v=Lonza
    Average 90 stars, based on 1 article reviews
    human umbilical artery smcs (huasmcs) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs (huasmcs  (Lonza)
    90
    Lonza human umbilical artery smcs (huasmcs
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs (Huasmcs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs/pmc04059065-197-25-31?v=Lonza
    Average 90 stars, based on 1 article reviews
    human umbilical artery smcs (huasmcs - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs huasmcs  (PromoCell)
    94
    PromoCell human umbilical artery smcs huasmcs
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs Huasmcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs/pm14597670-34-25-33?v=PromoCell
    Average 94 stars, based on 1 article reviews
    human umbilical artery smcs huasmcs - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Effects of bare and coating-modified groups on SMCs proliferation. (A–C) Representative fluorescence images of HUASMCs cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: Bioactive Materials

    Article Title: A hierarchical MgF 2 /polyurethane/pitavastatin coating alleviates degradation and enhances endothelialization of bioresorbable magnesium alloy stents

    doi: 10.1016/j.bioactmat.2025.08.038

    Figure Lengend Snippet: Effects of bare and coating-modified groups on SMCs proliferation. (A–C) Representative fluorescence images of HUASMCs cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: Human umbilical vein ECs (HUVECs), human umbilical artery SMCs (HUASMCs), and MΦs were obtained from Procell Life Science & Technology Co., Ltd. All cell lines were maintained and passaged in a cell culture incubator at 37 °C with 5 % CO 2 .

    Techniques: Modification, Fluorescence, Control, Expressing, Comparison